← Leaderboards
J. Thomas Thomas August
Johns Hopkins University
$11,740,601
Attributed
$11,740,601
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$11,740,601 · 5
By mechanism
U19$6,819,717 · 1
R37$4,110,855 · 1
R01$620,529 · 1
R03$163,500 · 1
RC1$26,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Jordan Green$12,034,081
- Stephen J Gould$8,380,884
- Karen L. Beemon$8,952,439
- Donald Straley Coffey$5,336,934
- Kevin M Myles$8,053,734
Others in their field
Top investigators on “Lysosomes”
- John H Wolfe · Children'S Hospital Of Philadelphia$28,702,493
- Robert A Wood · Johns Hopkins University$25,022,097
- Ramnik J Xavier · Broad Institute, Inc.$18,769,897
- Pin-Lan Li · Medical College Of Wisconsin$18,132,572
- Beth C Levine · Columbia University Health Sciences$17,892,677
- Ana M. Cuervo · Tufts University Boston$17,609,324
Research focus
LysosomesChimeric ProteinsMembrane ProteinsPrimatesAntigen PresentationVaccine DevelopmentMhc Class Ii AntigenDendritic CellsLaboratory MouseVector VaccineProtein TransportClinical ResearchResponseAntibodiesProgramsProteinsTissue /Cell CultureChimera OrganismAntigensDengue VirusPlasmidsCd4 Positive T LymphocytesDesignAntigen-Presenting Cells
Grant awards (20)
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$394,207
R37 · FY2011 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$398,189
R37 · FY2010 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$402,210
R37 · FY2009 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$402,210
R37 · FY2008 · AI · contact PI
Dengue Epitope Vaccine,Tetravalent & MHCII-Targeted$1,401,389
U19 · FY2007 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$409,896
R37 · FY2007 · AI · contact PI
Dengue Epitope Vaccine,Tetravalent & MHCII-Targeted$1,407,793
U19 · FY2006 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$399,144
R37 · FY2006 · AI · contact PI
Dengue Epitope Vaccine,Tetravalent &MHCII-Targeted$1,424,623
U19 · FY2005 · AI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$408,750
R37 · FY2005 · AI
Dengue Epitope Vaccine,Tetravalent &MHCII-Targeted$1,523,567
U19 · FY2004 · AI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$408,750
R37 · FY2004 · AI
Dengue Epitope Vaccine,Tetravalent &MHCII-Targeted$1,062,345
U19 · FY2003 · AI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$478,749
R37 · FY2003 · AI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$408,750
R37 · FY2002 · AI
HIV-1 GENE PRODUCTS TARGETED TO MHC II ANTIGEN PRESENTAT$322,904
R01 · FY2001 · AI
ADVANCES IN DNA VACCINES AGAINST EBOLA &DENGUE VIRUSES$81,750
R03 · FY2001 · AI
HIV-1 GENE PRODUCTS TARGETED TO MHC II ANTIGEN PRESENTAT$297,625
R01 · FY2000 · AI
ADVANCES IN DNA VACCINES AGAINST EBOLA &DENGUE VIRUSES$81,750
R03 · FY2000 · AI
NOVEL TECHNOLOGIES APPLIED TO A DENQUE DNA VACCINE$26,000
RC1 · FY2000 · AI